Today on Pharmaceutical Processing
PharmaEssentia commits to interferon therapy production amid shortage
PharmaEssentia has reaffirmed its commitment to creating access to critical interferon therapies amid a reported global shortage. The Burlington, Massachusetts-based company noted a recent reported shortage of Pegasys (peginterferon alfa-2a). With concerns growing over drug shortages for other therapies, the company said its established cGMP manufacturing network and patient-focused approach can help it meet the…
African Union vaccine initiative receives $45M
An African Union effort to strengthen public health and improve vaccine access in Africa has received a $45 million financing package. The U.S. International Development Finance Corporation, the African Development Bank and the International Finance Corporation (IFC) jointly announced the package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). This agreement underscores…
Sponsored Content See More >
Raumedic: A Trusted Partner in Serving the Pharmaceutical Industry with the Gold Standard in Silicone TubingRaumedic is a trusted partner in the international medical technology and pharmaceutical industry. The medical division of the global corporation…
Personalized medicine: advanced technology is saving livesThe concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies…
MES for Flexible, Paperless Pharmaceutical ProductionAll companies in the pharmaceutical industry are under pressure for time, quality, compliance, and innovation. These pressures create imperatives to…
Pave the way to high productivity with continuous manufacturing for pharmaContinuous manufacturing in the pharmaceutical industry is increasing as more manufacturers realize the benefits of the technology. But no two…
Revolutionizing Pharma Sustainability: Grundfos Solutions for Optimizing EfficiencyThis white paper highlights the pressing need for sustainability in the pharmaceutical industry, where energy-intensive processes contribute significantly to environmental…
The Evolution of Heat Sealingby Charles H. Trillich / Co-Founder Packworld USA Heat sealing technology has evolved over many decades to reduce cost and…
Difficult transmembrane protein targets for therapeutic antibodiesWhat is the current landscape of antibodies targeting membrane proteins? As of June 2022, 162 antibodies had been approved for…
Validatable Band Sealers for Medical PouchesBy Lynn Miranda, Sales Manager for All Packaging Machinery Corp, Ronkonkoma, NY. The customer’s level of confidence and trust is…
A new way to access scientific papers?Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to…
Anti-idiotype Antibodies: A Powerful Weapon for PK/ADA AssaysBy Sino Biological Therapeutic monoclonal antibodies have emerged as the fastest-growing class of therapeutics since the mid-1980s from the increasing…
Noble expands its services for its clients into Human FactorsHuman Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug…
Regulatory See More >
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
Merck recently won FDA approval for its sotatercept-csrk Winrevair for treating adults with pulmonary arterial hypertension. The drug was approved to increase exercise capacity and reduce the risk of clinical worsening events, according to the Rahway, N.J.-based company. It previously received FDA breakthrough designation and is the first FDA-approved action signaling inhibitor therapy for pulmonary…
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Eicos Sciences’ FDA-approved Aurlumyn promises to drastically reduce frostbite amputations
AbbVie launches Produodopa in the EU to treat Parkinson’s
FDA taking hands-off approach in enforcing medication promotion on TikTok
Learn how to rapidly develop smart and sustainable engineering and production processes See More >
Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >
Reckitt to make Mucinex in North Carolina
Reckitt Benckiser Group announced today that it is expanding its U.S. manufacturing footprint by acquiring a 310,000 ft² pharmaceutical site in Wilson, North Carolina. The Slough, U.K.–based company said it will invest £155 million ($200 million) to establish a manufacturing facility in Wilson to produce Mucinex tablets and liquids to meet increased U.S. demand. Reckitt…
Supply Chain See More >
PharmaEssentia commits to interferon therapy production amid shortage
PharmaEssentia has reaffirmed its commitment to creating access to critical interferon therapies amid a reported global shortage. The Burlington, Massachusetts-based company noted a recent reported shortage of Pegasys (peginterferon alfa-2a). With concerns growing over drug shortages for other therapies, the company said its established cGMP manufacturing network and patient-focused approach can help it meet the…
Recalls See More >
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…
